Shay Capital’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Shay Capital’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,411	Closed	-$51.6K	–	477
2024 Q1	$51.6K	Buy	+19,411	New	+$48.1K	0.01%	350

Shay Capital's KNTE Position: Q2 2024 in Review

Shay Capital sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 19,411 shares — an estimated $51.6K sold.

Shay Capital first reported a position in KNTE in Q1 2024 and held it in 1 quarter. The position peaked at $51.6K in Q1 2024. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

Shay Capital reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Shay Capital sold 19,411 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $51.6K.
Shay Capital first reported a position in Kinnate Biopharma Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Shay Capital's Kinnate Biopharma Inc. Common Stock position peaked at $51.6K in Q1 2024.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Shay Capital's 13F filing for Q2 2024, filed 14 Aug 2024.